Background

Senescent cells accumulate in bone marrow with aging and are known to impair hematopoietic and mesenchymal stem cell (MSC) function through the senescence-associated secretory phenotype (SASP). However, emerging evidence suggests extracellular vesicles (EVs) from senescent cells may carry epigenetic cargo independent of canonical SASP cytokines.

Hypothesis

Senescent osteoclasts release EVs enriched in miR-34a-5p, which is taken up by neighboring bone marrow MSCs, where it suppresses SIRT1 and NAMPT expression. This creates a local NAD+ deficit that accelerates epigenetic clock progression (measured by Horvath or GrimAge) specifically in MSCs, independent of systemic SASP signaling. This mechanism may explain why bone marrow exhibits accelerated biological aging relative to other tissues in individuals with high senescent cell burden.

Testable Predictions

1. In vitro: Co-culture of senescent osteoclasts with MSCs separated by a 0.4μm transwell (allowing EV but not cell contact) will accelerate MSC epigenetic age by ≥2 years (Horvath clock) over 14 days, an effect abolished by GW4869 (EV secretion inhibitor) but NOT by SASP-neutralizing antibody cocktail.
2. EV cargo: Small RNA-seq of senescent osteoclast EVs will show ≥3-fold enrichment of miR-34a-5p compared to non-senescent controls.
3. Mechanistic: AntagomiR-34a-5p treatment of MSCs will rescue SIRT1/NAMPT expression and NAD+ levels, preventing the epigenetic age acceleration.
4. In vivo: Dasatinib+quercetin (senolytic) treatment in aged mice will reduce bone marrow EV miR-34a-5p levels and slow MSC epigenetic aging more than it slows epigenetic aging in other tissues.

Significance

If confirmed, this identifies a SASP-independent, EV-mediated mechanism of paracrine senescence propagation that specifically targets stem cell epigenetic aging through NAD+ depletion. This has implications for: (1) tissue-specific aging rates, (2) targeted senolytic strategies focused on osteoclast senescence, and (3) potential NAD+ precursor supplementation as a tissue-specific anti-aging intervention in bone marrow.

Limitations

• Epigenetic clocks calibrated on bulk tissue may not accurately reflect single-cell-type aging
• GW4869 has off-target effects on ceramide metabolism
• miR-34a-5p has multiple targets beyond SIRT1/NAMPT